No Fear And No Panic After A 10% Correction = No Bottomtalkmarkets.comIn this video lesson, I discuss the overall market, my books, and my game plan moving forward after Friday's ugly sell-off.
Why Zai Lab (ZLAB) Stock Is Trading Higherbenzinga.comZai Lab shares are trading higher by 4% during Friday's session. The company priced a $200 million public offering.
NovoCure Q4 EPS Misses, Revenue Matchesfool.comNovoCure reported a solid jump in revenue, but earnings fell short due to rising costs and adoption challenges.
NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patientsbenzinga.comNovoCure and Zai Lab report PANOVA-3 trial success with TTFields therapy, achieving significant survival benefits for pancreatic cancer patients.
Zai Lab, A Top 6% Stock, Launched To A 16-Month High On Its 'Impressive' Resultsinvestors.comThe company is working on an antibody drug conjugate, which is like a smart bomb for cancer cells.
Why Is Zynex (ZYXI) Stock Down 24% Today?investorplace.comZynex stock is falling on Friday as ZYXI investor react to earnings misses and poor guidance for Q3 and the full year of 2024.
Why Is DexCom (DXCM) Stock Down 38% Today?investorplace.comDexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance.
Trade of the Day: Zai Lab (ZLAB) Stock Is a Possible Hidden Geminvestorplace.comA compelling hidden-gem opportunity, Zai Lab’s groundbreaking cancer therapeutic and discounted valuation could drive up ZLAB stock.
